The two-part test for grant of supplementary protection certificates is here to stay, but at what price?

Commentary on the Royalty Pharma Ruling of the CJEU of 30 April 2020. Full text: Comunicaciones ENG oct 2020 pag



Otras noticias

The worst discounts campaign

CEFI, as a member of the Interministerial Commission to act against activities which infringe intellectual and industrial property rights, backs the institutional anti-counterfeiting campaign carried out by the Ministry of Industry, Trade and Tourism together with the Spanish Patent and

Leer Más >>

The value of brands

Farmaindustria has published an interesting decalogue on the value of brands. It is important to strengthen the role of brands as industrial property and business assets that strengthen competitiveness in the market and inform us about their attributes. They highlight

Leer Más >>